Literature DB >> 11922911

Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs.

Martin Rodriguez-Porcel1, Lilach O Lerman, David R Holmes, Darcy Richardson, Claudio Napoli, Amir Lerman.   

Abstract

OBJECTIVE: Hypercholesterolemia (HC), a pro-oxidant condition, activates nuclear factor-kappa beta (NF-kappa B) and is associated with coronary endothelial dysfunction. The physiological significance of in vivo chronic antioxidant intervention on HC-induced NF-kappa B activation and coronary endothelial function remains unclear.
METHODS: Four groups of pigs were studied after 12 weeks of normal diet, normal diet with concomitant antioxidant intervention (100 IU/kg of vitamin E and 1 g of vitamin C daily), 2% HC diet, or HC diet+antioxidant supplementation. NF-kappa B activation and the nitric oxide (NO) pathway were investigated by Western blotting and immunohistochemistry, while oxidative stress was evaluated by coronary artery tissue radical scavenger activity and levels of vitamin E and C. Endothelial function was studied in vitro by coronary vasoreactivity to bradykinin and substance P.
RESULTS: HC animals had increased activation of NF-kappa B, decreased endothelial NO synthase expression, and decreased radical scavenger system activity, associated with impaired coronary endothelial function. Antioxidant supplementation in HC normalized NF-kappa B activation and NO bioactivity, and preserves coronary endothelial function.
CONCLUSIONS: This study demonstrates for the first time that in vivo chronic interruption of the endogenous oxidative stress cascade reduces HC-induced NF-kappa B activation and normalizes NO bioactivity in association with preservation of coronary endothelial function. This study suggests a role for increased oxidative stress and NF-kappa B activation in early atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922911     DOI: 10.1016/s0008-6363(01)00535-1

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  14 in total

1.  A Metabolic Intravascular Platform to Study FDG Uptake in Vascular Injury.

Authors:  F Franchi; M Olthoff; J Krier; C Noble; M Al-Hijji; V Ramaswamy; T Witt; M Burke; M Benscoter; A Lerman; G S Sandhu; M Rodriguez-Porcel
Journal:  Cardiovasc Eng Technol       Date:  2020-01-30       Impact factor: 2.495

Review 2.  Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury.

Authors:  Neeta Adhikari; Nathan Charles; Ute Lehmann; Jennifer L Hall
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

3.  Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease.

Authors:  Karen M Peterson; Federico Franchi; Darrel L Loeffler; Peter J Psaltis; Peter C Harris; Lilach O Lerman; Amir Lerman; Martin Rodriguez-Porcel
Journal:  Am J Nephrol       Date:  2013-08-30       Impact factor: 3.754

4.  Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.

Authors:  Martin Reriani; Eugenia Raichlin; Abhiram Prasad; Verghese Mathew; Geralyn M Pumper; Rebecca E Nelson; Ryan Lennon; Charanjit Rihal; Lilach O Lerman; Amir Lerman
Journal:  Circulation       Date:  2010-08-23       Impact factor: 29.690

5.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

6.  Activation of oxidative stress-responsive signaling pathways in early splenotoxic response of aniline.

Authors:  Jianling Wang; Gangduo Wang; G A S Ansari; M Firoze Khan
Journal:  Toxicol Appl Pharmacol       Date:  2008-03-04       Impact factor: 4.219

7.  Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location--determination of atherogenesis.

Authors:  M Gössl; D Versari; L O Lerman; A R Chade; P E Beighley; R Erbel; E L Ritman
Journal:  Atherosclerosis       Date:  2009-03-25       Impact factor: 5.162

Review 8.  Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond.

Authors:  Lilach O Lerman; Stephen C Textor; Joseph P Grande
Journal:  Prog Cardiovasc Dis       Date:  2009 Nov-Dec       Impact factor: 8.194

9.  Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells.

Authors:  Yoichi Takami; Hironori Nakagami; Ryuichi Morishita; Tomohiro Katsuya; Hiroki Hayashi; Masaki Mori; Hiroshi Koriyama; Yoshichika Baba; Osamu Yasuda; Hiromi Rakugi; Toshio Ogihara; Yasufumi Kaneda
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

10.  Impaired Hedgehog-Gli1 Pathway Activity Underlies the Vascular Phenotype of Polycystic Kidney Disease.

Authors:  Federico Franchi; Karen M Peterson; Katherine Quandt; David Domnick; Timothy L Kline; Michaela Olthoff; Mojtaba Parvizi; Ezequiel J Tolosa; Vicente E Torres; Peter C Harris; Martin E Fernandez-Zapico; Martin G Rodriguez-Porcel
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.